Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Temovatereg

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 969Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formosa Pharma & Saval Corporation License Clobetasol Propionate
    Formosa Pharma & Saval Corporation License Clobetasol Propionate

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-saval-corporation-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302438865.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share
    Cipla and Formosa sign licensing deal for Clobetasol Suspension
    Cipla and Formosa sign licensing deal for Clobetasol Suspension

    18 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cipla-and-formosa-sign-multi-regional-licensing-deal-for-clobetasol-suspension-302403405.html

    PR NEWSWIRE
    18 Mar 2025
    Share Share
    Formosa & Medvisis Announce Licensing Deal For Clobetasol
    Formosa & Medvisis Announce Licensing Deal For Clobetasol

    28 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-medvisis-switzerland-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302318160.html

    PR NEWSWIRE
    28 Nov 2024
    Share Share
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal

    31 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-davi-farmaceutica-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302292975.html

    PR NEWSWIRE
    31 Oct 2024
    Share Share
    Eyenovia Presents Phase 3 Clobetasol Study Results At AAO Expo
    Eyenovia Presents Phase 3 Clobetasol Study Results At AAO Expo

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2963893/0/en/Eyenovia-Announces-Presentation-of-Phase-3-Clobetasol-Study-Results-at-the-American-Academy-of-Ophthalmology-AAO-2024-Expo.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Formosa Ships APP13007 To US For Commercialization
    Formosa Ships APP13007 To US For Commercialization

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-makes-first-shipment-of-app13007-clobetasol-propionate-ophthalmic-suspension-0-05-to-the-united-states-for-commercialization-302241470.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share